Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene cuenta? Iniciar sesión
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- Materias primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
🤯 ¿Vio los resultados de ProPicks IA? ¡Más de 84.62% en 2024! Vea la lista de noviembre
Elija acciones con IA
Blackrock Global Funds - World Healthscience Fund D2 (0P0000XA93)
Agregar/Eliminar del portafolio
Agregar a portafolio
74.230
+0.150
+0.20%
03/11 - Mercado cerrado. Valores en EUR
Tipo:
Fondo
Mercado:
Luxemburgo
Emisor:
BlackRock (Luxembourg) SA
ISIN:
LU0827889485
Clase de activo:
Acciones
- Rating de Morningstar:
- Total de activos: 1.37B
BlackRock Global Funds - World Healthscience Fund
74.230
+0.150
+0.20%
Panorama 0P0000XA93
En esta página encontrará un perfil detallado de Blackrock Global Funds - World Healthscience Fund D2. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de 0P0000XA93, entre otros datos.
Información de contacto
Dirección
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Telefono
+44 20 77433000
Fax
Amsterdam
Ejecutivos
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Xiang Liu | Director | 2020 | Ahora |
| Biografía | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | Ahora |
| Biografía | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Biografía | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Biografía | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Escribe tus pensamientos respecto al Blackrock Global Funds - World Healthscience Fund D2
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores